KeyMed Biosciences Inc
F:64Z
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
KeyMed Biosciences Inc
F:64Z
|
CN |
|
D
|
Daiichi Life Group Inc
XMUN:QHH
|
JP |
|
G
|
Genuine Parts Co
XMUN:GPT
|
US |
|
Comfortdelgro Corporation Ltd
SGX:C52
|
SG |
|
F
|
Fifth Third Bancorp
DUS:FFH
|
US |
|
Banca Mediolanum SpA
MIL:BMED
|
IT |
|
A
|
AMETEK Inc
F:AK1
|
US |
|
British American Tobacco plc
LSE:BATS
|
UK |
|
L
|
Lincoln National Corp
DUS:LCO
|
US |
|
Freeport-McMoRan Inc
NYSE:FCX
|
US |
|
H
|
Hershey Co
DUS:HSY
|
US |
|
Genpact Ltd
NYSE:G
|
BM |
|
P
|
Paychex Inc
F:PCX
|
US |
|
S
|
SBM Offshore NV
DUS:IHCB
|
NL |
|
R
|
Raymond James Financial Inc
F:RJF
|
US |
|
C
|
China Oilfield Services Ltd
F:CO9
|
CN |
|
B
|
Banco Santander SA
XMUN:BSD2
|
ES |
|
HIAG Immobilien Holding AG
F:0HG
|
CH |
|
P
|
Papa John's International Inc
SWB:PP1
|
US |
|
K
|
Kraft Heinz Co
BMV:KHC
|
US |
|
Delivery Hero SE
F:DHER
|
DE |
|
Compagnie de Saint Gobain SA
OTC:CODGF
|
FR |
|
B
|
Blu Label Unlimited Group Ltd
XMUN:5TP
|
ZA |
Bankruptcy Probability
KeyMed Biosciences Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
KeyMed Biosciences Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CN |
K
|
KeyMed Biosciences Inc
HKEX:2162
|
21.8B HKD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
463.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
203.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
183.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
85B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
58.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
49.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
42B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
KeyMed Biosciences Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, KeyMed Biosciences Inc has total debt of 269.6m CNY. This includes both short-term (0 CNY) and long-term (269.6m CNY) debt.
You can find a full breakdown on its Balance Sheet.